Add Yahoo as a preferred source to see more of our stories on Google. Researchers believe prolonged use of the injectable contraceptive medroxyprogesterone acetate is associated with an excess risk of ...

Depot-medroxyprogesterone acetate is a commonly used injectable contraceptive that has been associated with an increased risk of HIV acquisition. This study compares effects of ...

Please provide your email address to receive an email when new articles are posted on . Prolonged use of medroxyprogesterone acetate injection associated with a 5.6-fold increased risk. Use of ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc., the Bill & Melinda Gates Foundation, and the Children’s Investment Fund Foundation (CIFF) today announced a multi-year extension of their collaboration to ...

Add Yahoo as a preferred source to see more of our stories on Google. A study has found the contraceptive injection increases risk of brain tumours, as ITV News' Cari Davies reports There is a small ...

Feb. 2, 2005 — The U.S. Food and Drug Administration (FDA) approved revisions to drug safety labeling last November, advising healthcare professionals of the following changes: use of ...

Teva Pharmaceutical Industries Ltd., TEVA announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) 150 ...

As of 2025, lawsuits are now underway against Pfizer, the manufacturer of Depo-Provera, filed by women who were diagnosed with meningioma after using the birth control shot. These cases allege that ...